Systems and methods for correcting and preventing occlusion in a catheter

Information

  • Patent Grant
  • 12005228
  • Patent Number
    12,005,228
  • Date Filed
    Monday, June 10, 2019
    5 years ago
  • Date Issued
    Tuesday, June 11, 2024
    5 months ago
Abstract
A patency device for catheter assemblies and other elongate tubular devices used for establishing access to an interior body portion of a patient is disclosed. The patency device establishes and preserves patency of one or more lumens defined by the catheter assembly by providing impulses of positive pressure to fluid disposed in the lumen of the catheter assembly. In one embodiment, the patency device comprises a fluid reservoir configured to provide a fluid path to at least one lumen of the catheter assembly, and a pressure input portion. The pressure input portion is configured to provide pressure for one or more impulses of positive pressure to a fluid disposed within the lumen. The impulses are configured to dislodge occlusions that may have formed in the lumen. A negative pressure can then be provided to the lumen to aspirate the occlusion.
Description
BRIEF SUMMARY

Briefly summarized, embodiments of the present invention are directed to a patency device for catheter assemblies and other elongate tubular devices used for establishing access to an interior body portion of a patient. The patency device establishes and/or preserves patency of one or more lumens defined by the catheter assembly by providing impulses of positive pressure to fluid disposed in the lumen of the catheter assembly.


In one embodiment, the patency device comprises a fluid reservoir configured to provide a fluid (or establish a fluid path) to at least one lumen of the catheter assembly, and a pressure input portion. The pressure input portion is configured to provide pressure for one or more impulses of positive pressure to a fluid disposed within the lumen. The impulses are configured to dislodge occlusions that may have formed in the lumen. A negative pressure can then be provided to the lumen to aspirate the occlusion and remove it from the catheter assembly.


These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 is a simplified view of a catheter assembly and a patency device attached thereto according to one embodiment;



FIG. 2 is a graph showing a pressure profile for the patency device of FIG. 1;



FIG. 3 is a block diagram of a patency device according to one embodiment;



FIGS. 4A and 4B are schematic diagrams of valve assemblies for the patency device of FIG. 3;



FIG. 5 is a block diagram of a patency device according to one embodiment;



FIG. 6 is a block diagram of a patency device according to one embodiment;



FIG. 7 is a block diagram of a patency device according to one embodiment;



FIG. 8 is a pressure profile for a patency device according to one embodiment;



FIG. 9 is a pressure profile for a patency device according to one embodiment;



FIG. 10 is a pressure profile for a patency device according to one embodiment; and



FIG. 11 is a block diagram of a patency device according to one embodiment.





DETAILED DESCRIPTION OF SELECTED EMBODIMENTS

Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.


For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”


Embodiments of the present invention are generally directed to catheter assemblies and other elongate tubular devices used for establishing access to an interior body portion of a patient. A peripherally inserted central catheter (“PICC”) is one example of such a catheter assembly. In particular, solutions and methods for establishing and preserving the patency of one or more lumens defined by the catheter assembly are disclosed. Examples of patency devices that may be employed are disclosed according to particular embodiments, discussed below.


Reference is first made to FIG. 1, which generally depicts various details of a catheter assembly (“catheter”), generally designated at 10, and a patency device, to be described further below, in accordance with one embodiment. As shown, the catheter 10 includes an elongate catheter tube 12 that defines a lumen 14 extending between a proximal end 12A and a distal end 12B of the catheter tube. A luer connector 22 or other suitable connector is included at the proximal end 12A of the catheter tube 12. In other embodiments, the catheter can include a bifurcation hub at the proximal end of the catheter tube, with one or more extension legs proximally extending therefrom.


Though shown here as defining a single lumen 14, the catheter 10 in other embodiments can define two or more lumens. Also, though shown as a PICC, the catheter in other embodiments can include other catheter types, such as dialysis, CVC, PIV, urinary, arterial, balloon catheters, etc. Thus, the discussion herein is not intended to be limiting.



FIG. 1 further shows details regarding a patency device 30 configured to operably connect on a temporary basis with the catheter 10 and provide patency to the catheter tube lumen 14, according to one embodiment. Generally, the patency device 30 includes a fluid reservoir 34 that is configured, together with a pressure input portion 38, to provide one or more relatively short-duration impulses, also referred to herein as positive pressure impulses, of high-pressure fluid to the lumen 14 of the catheter tube 12. Such impulses, when performed periodically, are configured to prevent the formation of thrombus or other occlusion in the lumen 14, especially at the distal end thereof. These short-duration, high pressure impulses can also be used to clear the lumen after occlusions have formed therein.


In greater detail, the pressure input portion 38 of the patency device 30 includes a mechanical input, such as a manual or motor-controlled plunger-type syringe, to impart pressure impulses to fluid contained in the fluid reservoir 34. The fluid reservoir 34 is configured to hold an amount of fluid that can be directed into the lumen(s) 14 of the catheter tube 12 prior to or in conjunction with the pressure impulses produced by the pressure input portion 38. In one embodiment and as seen below, the fluid reservoir 34 serves as a hydraulic accumulator to store pressurized fluid, produced by the pressure input portion 38, before its release to the lumen(s) 14.


It is noted that other types of pressure input portions can be utilized to provide high-pressure fluid impulses, including electrical and acoustic actuators, voice coil actuators, linear actuators, piezoelectric motors, vibrational drums and membrane, etc., for instance.


A catheter connector interface 40 defining a lumen 42 is included to enable the patency device 30 to operably connect to the luer connector 22 (or other portion) of the catheter 10 and provide a conduit through which the high pressure fluid can pass from the fluid reservoir 34 to the lumen(s) 14 of the catheter tube 12. Note that in one embodiment the connector interface 40 is a sterile item to bridge between the non-sterile patency device 30 and the catheter 10. In this way, the connector interface 40 can be manufactured as a disposable, sterile item, while the patency device 30 is reusable.


In operation, the patency device 30 emits periodic, relatively short-duration, relatively high-pressure bursts, or impulses, in the distal direction through the fluid-filled lumen 14 of the catheter tube 12. These impulses are produced by the pressure input portion 38 in conjunction with the pressure portion 34 and transmitted through the lumen 42 of the patency device 30 to the catheter tube lumen 14 via the connector interface 40 luer connector 22. It is appreciated that the pressure of the impulses, the impulse duration, the rest period between impulses, the frequency of successive impulses, etc., can be adjusted and varied according to the particular patency procedure being performed for the catheter 10.



FIG. 2 depicts a graph of a pressure profile 80 (including fluid pressure vs. time) produced by the patency device 30 during operation. The pressure profile 80 includes time on the x-axis and impulse pressure on the y-axis for operation of the patency device 30. As shown, the patency device 30 provides short-duration, relatively high-pressure impulses through the fluid present in the catheter tube lumen 14 interspersed by relatively longer rest periods 84 of negative baseline pressure provided to the catheter tube lumen. The negative baseline pressure present between impulses enables any occlusion dislodged by the impulses to be sucked proximally up the catheter tube lumen 14 and removed therefrom, thus preventing the dislodged occlusion from entering the bloodstream from the distal end 12B of the catheter tube 12. Note that the rest periods in other embodiments can include a reduction to a neutral pressure or lower (but still positive) pressure or to varying pressures over time as may be desired.



FIG. 2 further shows that successive impulse peaks 82 that represent the short-duration high-pressure fluid impulses are shown on the graph of the pressure profile 80. In the present embodiment, the pressure peaks 82 are each characterized by a rise-time phase of about 30 milliseconds, a holding high-pressure phase of about 200 milliseconds, and a pressure reduction phase of about 40 milliseconds. It is appreciated that these phases of the pressure peaks 82 can vary from the values given herein, and each pressure peak can vary in phase characteristics from previous and/or subsequent peaks. Also, the magnitude and duration of the impulses can vary from what is described herein and from one another.


In one embodiment, the pressure peaks 82 are modified by a controller of the patency device 30 so as to be customizable by the user. The rest periods 84 between the high-pressure fluid impulses (represented by the pressure peaks 82) can also be varied in duration, baseline pressure, etc.


In the present embodiment, the maximum pressure achieved by the impulses is about 400 psi, though this can vary according to desired application, catheter lumen design, type or size of occlusion, catheter tube length, etc. In one embodiment, it is appreciated that the maximum pressure of the impulses may exceed the burst pressure strength rating of the catheter tube 12 in one embodiment, but as the impulses are of relatively short duration, no rupturing or failure of the catheter 10 occurs.


As mentioned above, the high-pressure fluid impulses travel from the patency device 30 and into the catheter 10 so as to travel down the fluid-filled lumen 14 of the catheter tube 12. In one embodiment, the fluid filling the fluid path of the patency device and the catheter tube lumen 14 is a 0.9% saline solution, though other fluids may also be acceptably used. Note that the use of other fluids can necessitate altering the impulse characteristics (e.g., impulse pressure, impulse duration, rest period duration, etc.). As noted above, the high-pressure fluid impulses impinge on an occlusion (such as a clot or fibrin sheath) or other obstruction that has formed in the lumen 14, typically at or proximate the distal end 12B of the catheter tube 12. The occlusion is dislodged by the high-pressure impulses, which are strong enough to dislodge the occlusion but are not of sufficient duration to push it out the distal end 12B of the catheter tube 12. The subsequent negative pressure rest period following each impulse can act to prevent escape of the clot from the catheter tube 12, in one embodiment. In addition, a suction process can be performed by the patency device 30 to withdraw the clot proximally from the catheter tube 12 and catheter 10 and into the patency device, where it may be disposed of. In this way, any clot or occlusion present in the catheter 10 can be acceptably removed.



FIG. 3 depicts the patency device 30 according to one embodiment. As shown, the patency device 30 includes a hydrostatic pump 138 that serves as the pressure input portion 38 for providing hydraulic pressure to fluid contained and maintained at pressure in a hydraulic accumulator (“accumulator”) 134 that serves as the fluid reservoir 34. A two-way, normally closed (“N.C.”) valve 140 is disposed at and operably connected at its fluid inlet to a fluid outlet of the accumulator 134 via a fluid line. A pressure transducer 144 is operably interposed between the fluid outlet of the N.C. valve 140 and the luer connector 22 or other suitable inlet to the catheter. As mentioned above, in this and other embodiments the connector interface 40 (FIG. 1) can be used to operably connect the patency device 30 to the catheter 10. Note that the fluid lines between the various components discussed herein can include tubing or other suitable modes for fluid transport.


A two-way, normally open (“N.O.”) valve 150 is interposed between the N.C. valve 140 and the transducer 144 via a fluid line connected to the N.O. valve fluid inlet. A vacuum input portion 160 for providing negative pressure in the patency device 30 is operably connected to the fluid outlet of the N.C. valve 150. In the present embodiment, a syringe pump 162 serves as the vacuum input portion 160, though other suitable components can also be employed, such as a vacuum pump. A controller 170 is operably connected to the aforementioned components of the patency device 30 to govern their operation. The controller 170 in one embodiment includes a power source, a printed circuit board including a processor, etc.



FIG. 4A depicts various details regarding a valve control assembly 180 associated with the N.C. valve 140 shown in the patency device 30 of FIG. 3, according to one embodiment. As shown, the valve control assembly 180 includes a relay 182 and a power diode operably interconnected with the N.C. valve 140. A power supply 186 is included for the N.C. valve 140, as is a power supply 188 for the relay 182. FIG. 4B shows a similar configuration for the valve control assembly 180 associated with the N.O. valve 150 of the patency device 30 of FIG. 3, including a relay 182 and a power diode operably interconnected with the N.O. valve. A power supply 186 is included for the N.O. valve 150, as is a power supply 188 for the relay 182. The valve control assemblies 180 for the N.C. valve 140 and the N.O. valve 150 assist in governing operation of the N.C. and N.O. valves during operation of the patency device 30. In the present embodiment, the N.C. valve 140 and the N.O. valve 150 are gate-valve types of valves, though it is appreciated that other suitable types of valves can be utilized. In another embodiment, the functionality of the N.C. valve 140 and the N.O. valve 150 can be combined into a single valve, such as a three-way valve, with the fluid lines being arranged so as to provide such an embodiment. In such a single valve embodiment, the single three-way valve is operated to alternately provide the impulses of positive pressures as well as the negative baseline pressures/negative impulses.


The patency device 30 of FIG. 3 is operably attached to luer connector 22 of the catheter 10 when a patency procedure (a procedure to clear the catheter tube lumen(s) 14 of an occlusion or to prevent formation thereof) is desired by a clinician or catheter user. In operation, the patency device 30 first provides fluid pressure via actuation—either manually or by automatic/motor modes—of the hydrostatic pump 138. The pressurized fluid is received from the pump 138 by the accumulator 134, which stores the fluid in a pressurized state until needed. The N.O. valve 150 is maintained in an open state at the beginning and during the procedure to maintain a negative base pressure in the system except at those times when the N.C. valve 140 is opened to provide the fluid impulses. The controller 170 or other suitable component can control valve opening/closing.


The controller 170 determines the number, frequency, rest periods, etc., of the impulses to be delivered by the patency device 30 to the catheter tube lumen(s) 14. The N.C. valve 140 is opened and close repeatedly at predetermined time intervals to provide a series of fluid impulses from the accumulator, through the N.C. valve and into the lumen 14 of the catheter 10. During each impulse when the N.C valve 140 is opened, the N.O valve 150 is shut so as to prevent impulse fluid from entering the N.O. valve and diverting to the syringe pump 162 instead of entering the catheter tube lumen 14 as desired. The impulses are propagated distally down the lumen 14, which is fluid-filled prior to commencement of the patency operation so as to provide a propagation medium for the impulses.


Between each impulse and after the series of impulses has ended, the N.C. valve 140 closes and the N.O. valve 150 opens to provide a negative baseline pressure (provided by the syringe pump 162 or other suitable device) in the catheter tube lumen 14 and enable any occlusion dislodged by the impulses to be suctioned proximally out of the lumen, through the N.O. valve to the syringe pump 162. An appropriate capture reservoir or the like can be operably connected to the syringe pump to provide for retention of occlusions and fluid if needed. The controller 170 is utilized to precisely control the opening/closing of the N.C. valve 140 and the N.O. valve 150 so as to provide the impulses and the negative baseline pressure to the lumen 14 as desired.


In one embodiment, it is appreciated that the baseline negative pressure periods existing between the positive pressure impulses can be replaced or supplemented with relatively short-duration impulses of negative pressure to further assist in occlusion dislodgement. Subsequent negative baseline pressure can then be used to remove the occlusion to the lumen 14. In one embodiment, the response time of the valves 140 and 150 is sufficiently fast to enable the positive pressure impulses to be followed in quick succession by the negative baseline pressure or negative pressure impulse.


The pressure transducer 144 is utilized and controlled by the processor 170 to measure the pressure of the impulses delivered to the catheter tube lumen 14 by the patency device 30. As mentioned, the pressure level of the impulses can be varied or determined according to a variety of factors, including catheter length, catheter lumen size, burst strength, impulse duration, rest period duration, other catheter configuration, etc. In one embodiment, the pressure of each impulse can be chosen from a range of from about 30 psi to about 120 psi, though other pressure below and above this are possible. Also, frequency of the impulses, or impulse frequency, can be set according to a predetermined pattern and can vary according to a number of factors such as those described immediately above and can range in one embodiment from about 1 to over about 150 Hz, though other frequency ranges are also possible. In one embodiment, the impulse frequency is set to match the resonant frequency of the catheter 10 itself, thus enabling improved propagation of the impulses distally through the lumen 14. In one example, for instance, the resonant frequency of a 3 Fr single lumen catheter assembly was found to be about 30 Hz for catheter tube lengths of from about 35 cm to about 55 cm. The resonant frequency will vary according to a number of catheter characteristics. In one embodiment, for instance, resonant frequencies for various catheters vary from about 15 Hz to about 50 Hz, though other frequencies are possible.


In one embodiment, the impulse frequency is above about 20 KHz, thus performing as an ultrasound impulse signal to dislodge lumen occlusions or maintain lumen patency. These ultrasonic signals are of sufficient frequency, intensity, and duty cycle as to dislodge the occlusion(s) present in the lumen(s) 14. In one embodiment, the patency device 30 can include a an ultrasound module operably connectable to the luer connector 22 or extension leg of the catheter 10 and further includes an ultrasound transducer for providing ultrasonic impulses to the fluid-filled lumen 14. The patency device 30 can further include ports to enable fluids or other substances to be infused into or aspired from the catheter tube lumen(s) 14, such as antimicrobial agents, etc.


Note that the patency device 30 is either externally powered or can include its own power source, such as a battery. Note further that in one embodiment that the controller 170 can enable customization of the characteristics of the impulses, rest periods, baseline pressure, etc. by the user.


It is appreciated that periodic use of the patency devices described herein can also serve to prevent the formation of an occlusion by preventing initial adherence and growth of the occlusion in the first place, as mentioned herein. In one embodiment, the patency device is self-operating, thus serving as a passive solution to preventing occlusions.


Note that in one embodiment a pressure regulator can be employed to provide and/or maintain pressurized fluid in the patency device 30. Note also that it is appreciated that adjustments may be made to the pressure of the impulses to compensate for pressure loss/attenuation as a function of the distance the impulse travels distally through the catheter tube lumen 14.


In light of the above, it is appreciated that in one embodiment, a method for providing patency to at the lumen(s) 14 the catheter assembly 10 comprises disposing a fluid in the lumen of the catheter tube 12 of the catheter; and propagating a plurality of impulses of positive pressure through the fluid disposed in the lumen, noting that the impulses are propagated in a predetermined pattern.


The patency device of FIG. 5 replaces the gate valve-type of valves with tubing pinch valves for the N.C valve 140 and the N.O. valve 150. Such valves operate by pinching off a portion of the tubing that comprises the fluid lines, such as the illustrated high pressure tubing 194 proximate the N.O. pinch valve 150, so as to stop fluid flow therethrough. The valve releases the pinch-off of the tubing to enable fluid flow anew therethrough. These and other valve types are therefore contemplated.



FIG. 6 depicts details of the patency device 30 according to another embodiment, wherein the pressure input portion 38 includes an actuator, such as a voice coil actuator 200 configured to provide mechanical movement for the formation of the desired fluid pressure impulses. A servo drive 214 is operably connected to the voice coil actuator 200 to assist in actuator function. A piston 202 (or plunger or the like) is operably connected to the voice coil actuator 200, which in turn is operably connected to the fluid reservoir 34, here a fluid-containing syringe 206. The syringe 206 in the present embodiment is a high pressure syringe. The piston 202 is sized to be received within a proximal end of the syringe 206 so as to enable the piston to transfer the mechanical movements of the voice coil actuator to the fluid present in the syringe to create the desired impulses. Impulses produced in the fluid of the syringe 206 are forwarded past a valve 210 and into the lumen 14 of the catheter tube 12. A hub adapter 208 is included in the present embodiment to enable the valve 210 to operably connect to the catheter 10.


The valve 210 is operable, such as by 170 controller, to selectively open to enable the impulses produced by the aforementioned components to pass through to the catheter lumen 14. At all other times during a patency procedure, the valve 210 is switched to enable a negative baseline pressure to be imparted to the catheter lumen 14 via the syringe pump 162 in manner similar to embodiments discussed above. In one embodiment, pressure of the impulses produced by the patency device 30 of FIG. 6 are measured from about 60 psi to more than about 100 psi, though this can vary according to system design.



FIG. 7 depicts details of the patency device 30 according to another embodiment, wherein the pressure input portion 38 includes a wave generator 220, such as a loudspeaker, to produce energy for the formation of the desired fluid impulses. A signal generator 224 produces voltage waveforms, or driving signals, to actuate the wave generator in a desired pattern for the impulses, the signals of the signal generator being amplified by an amplifier 226. In one embodiment, pressure of the impulses produced by the patency device 30 of FIG. 7 are measured at about 40 psi or less, though this can vary according to system design.


A piston, such as a plunger, is operably connected to the movable cone of the loudspeaker of the wave generator 220 is received within the fluid-containing syringe 206, serving as the fluid reservoir 34. Operation of the loudspeaker moves the cone thereof in accordance with the driving signals received and amplified by the signal generator 224 and amplifier 226, which in turn moves the plunger in accordance with the driving signals. The fluid contained in syringe 106 is moved by the plunger, which produces the desired fluid impulses that are propagated distally through the lumen 14 of the catheter 10 via the hub adapter 208. In one embodiment, the impulses produced by the patency device of FIG. 7 are in a frequency range of from about 1 to about 200 Hz, though a variety of other frequencies are possible.


The embodiments of the patency device 30 shown and described in connection with FIGS. 3, 5, 6, and 7 are therefore representative of a multitude of a variety of patency devices that can be employed to provide fluid impulses for the dislodgement of occlusive material within the lumen of a catheter and/or to maintain the patency of the lumen, free from occlusions.



FIGS. 8-10 depict various operation cycles for the positive pressure impulses produced by the present patency device, such as the patency device 30 shown in FIG. 6, for instance. FIG. 8 shows a pulse profile 280 including a continuous series of equal (in terms of energy, pressure) impulses delivered to the catheter tube lumen 14 (FIG. 1) at a set impulse frequency and returning to a baseline pressure 284 before starting the next impulse. The frequency can be any one or more of a variety of impulse frequencies, including ultrasonic frequencies (e.g., above 20 KHz).


In FIG. 9, a series of groups of impulses is shown, wherein groups of impulses are separated by rest periods 286 of nominal baseline pressure 284, such as a low positive pressure, which pattern is useful for when no occlusion is present but impulses are used to keep the lumen 14 patent.


In FIG. 10, a series of groups of impulses is shown, wherein groups of impulses are separated by rest periods 286 of negative baseline pressure 284 to enable aspiration from the catheter 10 of any occlusions dislodged by the impulses, as discussed further above. In these and the other examples herein, note that the number of impulses in each group can vary according to user desire and/or a pre-set predetermined pattern, as can the pressure, frequency, etc. Note that frequency use of the patency device 30 can vary from continuously, hourly, daily, weekly, occasionally, etc., depending on whether the intended use is prophylactic or corrective, the amount of occlusion present, etc.



FIG. 11 depicts details of the patency device 30 including the pressure input portion 38, including a hydrostatic pump or other suitable component as described herein or appreciated. A membrane 290 is included and configured to move/vibrate when acted upon by the positive pressure produced by the pressure input portion 38, thus producing impulses of positive pressure that are propagated through fluid disposed in a valve 294, such as a three-way valve, before travelling through the fluid-filled luer connector 22 and the lumen 14 of the catheter 10 to provide patency thereto. A vacuum input portion 160 is provided to supply negative baseline pressure/negative pressure impulses to fluid in the lumen 14 when the valve 294 is actuated to provide fluid communication therebetween. It is appreciated that no fluid reservoir 34 is included in the present embodiment. The embodiment shown in FIG. 11 can include a T-connector to provide the illustrated structure, in one embodiment.


Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A catheter assembly, comprising: a catheter including a lumen; anda patency device connectable to the catheter, the patency device comprising: a fluid reservoir designed to be placed in fluid communication with the lumen;a positive pressure input portion having a distal end connected to the fluid reservoir, designed to provide at least one impulse of positive pressure to a fluid disposed within the lumen;an interface portion including a proximal end coupled to the fluid reservoir and a distal end coupled to the lumen;a normally closed two-way valve coupled in line between the fluid reservoir and the lumen; anda negative pressure input portion operably connected to a fluid outlet of the normally closed two-way valve.
  • 2. The catheter assembly according to claim 1, wherein the at least one impulse is designed to dislodge an occlusion disposed in the lumen.
  • 3. The catheter assembly according to claim 1, wherein the negative pressure input portion comprises a vacuum device.
  • 4. The catheter assembly according to claim 3, wherein the vacuum device comprises a syringe pump or a vacuum pump.
  • 5. The catheter assembly according to claim 3, wherein the vacuum device comprises a normally open valve.
  • 6. The catheter assembly according to claim 5, wherein the normally open valve is designed to close upon opening of the normally closed two-way valve.
  • 7. The catheter assembly according to claim 1, wherein the at least one impulse includes a series of impulses at a predetermined impulse frequency, and wherein the interface portion is disposable and provides a sterile barrier between the catheter and the patency device.
  • 8. The catheter assembly according to claim 7, wherein the predetermined impulse frequency is at least 20 KHz.
  • 9. The catheter assembly according to claim 1, wherein the positive pressure input portion is designed to provide multiple series of impulses in a predetermined impulse pattern, each of the multiple series including the at least one impulse.
  • 10. The catheter assembly according to claim 9, wherein each of the multiple series of the impulses is separated by a rest period.
  • 11. The catheter assembly according to claim 10, wherein the patency device is designed to provide a negative pressure to the fluid disposed within the lumen during each rest period.
  • 12. The catheter assembly according to claim 1, wherein the patency device is designed to provide the at least one impulse at a pressure of at least 30 psi.
  • 13. The catheter assembly according to claim 1, wherein the patency device is designed to provide the at least one impulse at a pressure that exceeds a burst pressure strength rating of the catheter.
  • 14. The catheter assembly according to claim 1, further comprising a pressure transducer designed to provide data relating to a pressure within a fluid line of the patency device.
  • 15. The catheter assembly according to claim 1, further comprising a controller designed to govern operation of the patency device, the controller including a processor.
  • 16. The catheter assembly according to claim 1, wherein the positive pressure input portion includes at least one of a hydrostatic pump, an actuator, and a wave generator.
  • 17. The catheter assembly according to claim 1, wherein the fluid reservoir includes at least one of a hydraulic accumulator and a syringe.
  • 18. The catheter assembly according to claim 1, wherein the at least one impulse includes a rise-time phase of about 30 milliseconds, a holding high-pressure phase of about 200 milliseconds, and a pressure reduction phase of about 40 milliseconds.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/619,219, filed Jun. 9, 2017, now U.S. Pat. No. 10,322,230, which claims the benefit of U.S. Provisional Application No. 62/348,082, filed Jun. 9, 2016, and titled “Systems and Methods for Correcting and Preventing Occlusion in a Catheter,” each of which is incorporated by reference in its entirety into this application.

US Referenced Citations (156)
Number Name Date Kind
3941122 Jones Mar 1976 A
4155362 Jess May 1979 A
4191184 Carlisle Mar 1980 A
4446867 Leveen et al. May 1984 A
4551041 Coon et al. Nov 1985 A
4692139 Stiles Sep 1987 A
4698058 Greenfeld et al. Oct 1987 A
4781677 Wilcox Nov 1988 A
4808153 Parisi Feb 1989 A
4870953 DonMicheal et al. Oct 1989 A
4929242 Desecki et al. May 1990 A
4959050 Bobo, Jr. Sep 1990 A
5006304 Franklin et al. Apr 1991 A
5267565 Beard Dec 1993 A
5269291 Carter Dec 1993 A
5273027 Sekino et al. Dec 1993 A
5318014 Carter Jun 1994 A
5354273 Hagen Oct 1994 A
5427118 Nita et al. Jun 1995 A
5431663 Carter Jul 1995 A
5480379 La Rosa Jan 1996 A
5536242 Willard et al. Jul 1996 A
5592866 Sher Jan 1997 A
5807343 Tucker Sep 1998 A
5916192 Nita et al. Jun 1999 A
5925016 Chornenky et al. Jul 1999 A
5935146 McEwen et al. Aug 1999 A
6001069 Tachibana et al. Dec 1999 A
6007514 Nita Dec 1999 A
6024718 Chen et al. Feb 2000 A
6027450 Brown et al. Feb 2000 A
6126619 Peterson et al. Oct 2000 A
6135977 Drasler et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6149596 Bancroft Nov 2000 A
6210404 Shadduck Apr 2001 B1
6371928 Mcfann et al. Apr 2002 B1
6398714 Verkerke et al. Jun 2002 B1
6433464 Jones Aug 2002 B2
6435189 Lewis et al. Aug 2002 B1
6471689 Joseph et al. Oct 2002 B1
6602264 McGuckin, Jr. Aug 2003 B1
6617760 Peterson et al. Sep 2003 B1
6652547 Rabiner et al. Nov 2003 B2
6676637 Bonnette et al. Jan 2004 B1
6685657 Jones Feb 2004 B2
6689109 Lynn Feb 2004 B2
6723064 Babaev Apr 2004 B2
6740059 Flaherty May 2004 B2
6852097 Fulton, III Feb 2005 B1
6855123 Nita Feb 2005 B2
6921371 Wilson Jul 2005 B2
6945951 Bonnette et al. Sep 2005 B1
6979293 Hansmann et al. Dec 2005 B2
7144381 Gertner Dec 2006 B2
7220233 Nita et al. May 2007 B2
7220239 Wilson et al. May 2007 B2
7255690 Gray et al. Aug 2007 B2
7297131 Nita Nov 2007 B2
7335180 Nita et al. Feb 2008 B2
7341569 Soltani et al. Mar 2008 B2
7393338 Nita Jul 2008 B2
7648478 Soltani et al. Jan 2010 B2
7686825 Hauser et al. Mar 2010 B2
7717853 Nita May 2010 B2
7789830 Ishida et al. Sep 2010 B2
7828762 Wilson et al. Nov 2010 B2
7918822 Kumar et al. Apr 2011 B2
7955293 Nita et al. Jun 2011 B2
7993308 Rule et al. Aug 2011 B2
7998121 Stringham Aug 2011 B2
8043251 Nita et al. Oct 2011 B2
8052704 Olson Nov 2011 B2
8062316 Patel et al. Nov 2011 B2
8083707 Tosaya et al. Dec 2011 B2
8152753 Nita et al. Apr 2012 B2
8162924 Boyden et al. Apr 2012 B2
8167831 Wilson et al. May 2012 B2
8317770 Miesel et al. Nov 2012 B2
8348880 Messerly et al. Jan 2013 B2
8366620 Nita Feb 2013 B2
8414569 Manwaring et al. Apr 2013 B2
8435225 Courtney May 2013 B2
8617096 Nita et al. Dec 2013 B2
8622911 Hossack et al. Jan 2014 B2
8632560 Pal et al. Jan 2014 B2
8647293 Nita Feb 2014 B2
8758519 Waldmann et al. Jun 2014 B2
8827953 Rocha-Singh Sep 2014 B2
8852166 Keilman et al. Oct 2014 B1
8876795 Fiering et al. Nov 2014 B2
8956386 Hauser et al. Feb 2015 B2
8999070 MacKenzie Apr 2015 B2
9028748 Zumeris et al. May 2015 B2
9107590 Hansmann et al. Aug 2015 B2
9144693 Appelman et al. Sep 2015 B2
9198680 Fraser et al. Dec 2015 B2
9254144 Nguyen et al. Feb 2016 B2
10245401 Cuevas Apr 2019 B2
10322230 Ofek et al. Jun 2019 B2
20020151825 Rubenchik et al. Oct 2002 A1
20040019318 Wilson et al. Jan 2004 A1
20040210140 Rabiner et al. Oct 2004 A1
20050027265 Maki et al. Feb 2005 A1
20050209578 Christian Evans et al. Sep 2005 A1
20050215942 Abrahamson et al. Sep 2005 A1
20050220711 Katz Oct 2005 A1
20060173387 Hansmann et al. Aug 2006 A1
20060241524 Lee et al. Oct 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20070167798 Cai et al. Jul 2007 A1
20070213681 Manna et al. Sep 2007 A1
20070239027 Nita Oct 2007 A1
20070265560 Soltani et al. Nov 2007 A1
20080097206 Chomas et al. Apr 2008 A1
20080125657 Chomas et al. May 2008 A1
20080243153 Nguyen et al. Oct 2008 A1
20090018472 Soltani et al. Jan 2009 A1
20090088724 Chebator et al. Apr 2009 A1
20090118663 Rockley et al. May 2009 A1
20090157003 Jones et al. Jun 2009 A1
20090177158 Krumme Jul 2009 A1
20100004534 Neer Jan 2010 A1
20100010393 Duffy et al. Jan 2010 A1
20100076370 Howlett Mar 2010 A1
20100094201 Mallaby Apr 2010 A1
20100217276 Garrison et al. Aug 2010 A1
20100249719 Fojtik Sep 2010 A1
20100262215 Gertner Oct 2010 A1
20100286708 Rittman Nov 2010 A1
20110046522 Chan et al. Feb 2011 A1
20110087147 Garrison et al. Apr 2011 A1
20110112564 Wolf May 2011 A1
20110144540 Shen et al. Jun 2011 A1
20120059285 Soltani et al. Mar 2012 A1
20120179073 Nita Jul 2012 A1
20120232434 Nita et al. Sep 2012 A1
20120232435 Nita et al. Sep 2012 A1
20120232465 Nita et al. Sep 2012 A1
20120238916 Nita et al. Sep 2012 A1
20120238946 Nita et al. Sep 2012 A1
20120289889 Genstler et al. Nov 2012 A1
20130116603 Nita May 2013 A1
20130138082 Salahieh May 2013 A1
20130331738 Borrelli Dec 2013 A1
20140107481 Wulfman Apr 2014 A1
20140155922 Nita Jun 2014 A1
20150025543 Nita et al. Jan 2015 A1
20150025544 Nita et al. Jan 2015 A1
20150094595 Havel et al. Apr 2015 A1
20150141817 Chen et al. May 2015 A1
20150190660 Sarge et al. Jul 2015 A1
20150196309 Matsubara et al. Jul 2015 A1
20150320432 Adams Nov 2015 A1
20150352379 Appelman et al. Dec 2015 A1
20170354777 Ofek et al. Dec 2017 A1
Foreign Referenced Citations (8)
Number Date Country
9211891 Jul 1992 WO
2014043650 Mar 2014 WO
14149648 Sep 2014 WO
14151209 Sep 2014 WO
15029039 Mar 2015 WO
2015074032 May 2015 WO
15157330 Oct 2015 WO
2017214573 Dec 2017 WO
Non-Patent Literature Citations (15)
Entry
EP 17811123.3 filed Jan. 9, 2019 Extended European Search Report dated Jan. 13, 2020.
Atar S, Neuman Y, Miyamoto T, Chen M, Birnbaum Y, Luo H, Kobal S, Siegel RJ. “Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.” J Thromb Thrombolysis. Jun. 2003; 15(3):165-9.
Doomernik DE, Schrijver AM, Zeebregts CJ, de Vries JP, Reijnen MM. “Advancements in catheter-directed ultrasound-accelerated thrombolysis.” J Endovasc Ther. Jun. 2011; 18(3):418-34.
EKOS EkoSonic Ultrasound Endovascular System—designed to treat intravascular clots using ultrasound technology https://www.btg-im.com/en-US/EKOS/Products/EkoSonic-EndoVascular-System, last accessed Jun. 9, 2017.
Emmi-dent—Ultrasound emitting oral toothbrush designed to prevent biofilm formation and remove bacteria on teeth (http://www.emmi-dent.com) Last accessed Jun. 9, 2017.
Joyce E, Phull SS, Lorimer JP, Mason T J. “The development and evaluation of ultrasound for the treatment of bacterial suspensions. A study of frequency, power and sonication time on cultured Bacillus species.” Ultrason Sonochem. 2003.
Mason T J, Joyce E, Phull SS, Lorimer JP. “Potential uses of ultrasound in the biological decontamination of water.” Ultrason Sonochem. Oct. 2003;10(6):319-23.
Mourad PD, Roberts FA, Mcinnes C. “Synergistic use of ultrasound and sonic motion for removal of dental plaque bacteria.” Compend Contin Educ Dent. Jul. 2007;28(7):354-8.
Neuman Y, Rukshin V, Tsang V, Atar S, Miyamoto T, Luo H, Kobal S, Thompson T, Birnbaum Y, Horzewski M, Siegel RJ, Kaul S. “Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An exvivo canine shunt study.” Thromb Res. 2003;112(1-2):99-104.
Owens CA. “Ultrasound-Enhanced Thrombolysis: EKOS EndoWave Infusion Catheter System.” Seminars in Interventional Radiology. 2008;25(1):37-41.
Pajek D, Burgess A, Huang Y, Hynynen K. “High-intensity focused ultrasound sonothrombolysis: the use of perfluorocarbon droplets to achieve clot lysis at reduced acoustic power.” Ultrasound Med Biol. Sep. 2014;40 (9):2151-61.
U.S. Appl. No. 15/619,219, filed Jun. 9, 2017 Non-Final Office Action dated Jul. 26, 2018.
U.S. Appl. No. 15/619,219, filed Jun. 9, 2017 Notice of Allowance dated Feb. 8, 2019.
Wright C, Hynynen K, Goertz D. “In vitro and in vivo high-intensity focused ultrasound thrombolysis.” Invest Radial. Apr. 2012;47(4):217-25.
PCT/US2017/036866 filed Jun. 9, 2017, International Search Report and Written Opinion dated Aug. 16, 2017.
Related Publications (1)
Number Date Country
20190290838 A1 Sep 2019 US
Provisional Applications (1)
Number Date Country
62348082 Jun 2016 US
Continuations (1)
Number Date Country
Parent 15619219 Jun 2017 US
Child 16436726 US